JUNE 17-19, 2024
WASHINGTON, DC    

 

Tissue Engineering and Disease Modeling


Submit Abstract - due April 1 »

Please first review the information for authors — abstract submission guidelines.

Symposium Chair

Thomas J. WebsterThomas J. Webster
Chief Scientific Advisor
Interstellar Therapeutics

 

Key Speakers

Sougata GhoshSougata Ghosh
Visiting Professor
RK University

Gregory GuisbiersGregory Guisbiers
Assistant Professor of Physics and Astronomy
University of Arkansas Little Rock

Houssam Bouloussa4D Printing Technology Confers Remote Control Shape Change Properties to Biomaterials
Houssam Bouloussa
Assistant Professor, University of Missouri - Kansas City

Tissue engineering encompasses aspects of cells, materials, and biochemical, and physiochemical cues to restore, maintain, or replace tissue function. Disease modeling, whether it be in vitro or in vivo, aims to establish systems that resemble human diseases to improve our understanding of the mechanism of diseases or develop new therapies and diagnostic tools. Though these two areas are distinctly different in their end goals, there is significant conceptual and design overlap. Presentations in this session focus all aspects of tissue engineering or disease modeling including biomaterials, cells, growth factors, mechanical stimuli, and in vivo models and testing.

 
Back to Top ↑

2023 Symposium Sessions

9:00Tissue Engineering
4:00Tissue Engineering - Posters

2023 Symposium Program

Monday June 19

9:00Tissue EngineeringChesapeake 12
Session chair: Thomas Webster, Interstellar Therapeutics, US
9:00A Novel, Biocidal and Permanent Surface Modification Technology to Protect Medical and Non-Medical Surfaces
H. Bouloussa, DeBogy Molecular, Inc., US
9:25Bacterial and human cell-synthesized metal nanomaterials: turning bacterial pathogens and human cells into clinical assets
D. Medina Cruz, SynCell Biotechnology, US
9:50Design of Biomimetic ECM-like Matrices for Guided Tissue Formation
H. Wang, Stevens Institute of Technology, US
10:15Break
10:25Converged Biofabrication Technologies for High-Content Tissue Model Engineering
Y. Shrike Zhang, Harvard Medical School, US
10:50Human Clinical Tissue Engineering Trials
T.J. Webster, Interstellar Therapeutics, US
11:10Gelatin Methacryloyl Granular Hydrogels: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting
A. Sheikhi, The Pennsylvania State University, US
11:30Absolute Quantification of Genomic Targets for Cell Counting
M. Cauble, H-J He, J. Almeida, S. Sarkar, National Institute of Standards and Technology, US
11:50Light Transmission Aggregometry Method to Measure Tumor Cell Cluster Dissociation
B. Schnoor, R.K. Kottana, A.L. Papa, George Washington University, US
4:00Tissue Engineering - PostersExpo Hall AB
Developing Customizable Scaffolds with Antimicrobial Properties for Vascular Tissue Regeneration using Low Temperature Plasma (LTP)
K. Vig, Alabama State University, US
Topics & Application Areas
  • Cell sourcing
  • Genetic and metabolic engineering
  • Growth factor and cytokines
  • Tissue stimulation devices
  • Biomaterials for tissue engineering or disease modeling
  • Three-dimensional cell culture models
  • Organ-on-a-chip
  • Microphysiological systems
  • Drug screening platforms
  • Engineered models of diseases
  • Animal models
  • Models to study host-microorganism interactions and infections
  • Other
 

Sponsor & Exhibitor Opportunities
 

To receive announcements and news, please join our mailing list.

Click here to add this event to your calendar.
..  
 
SPONSORS & PARTNERS
Sponsors & Partners
 
SBIR/STTR AGENCY PARTNERS
SBIR/STTR Agency Partners